Bio Impact Capital LLC Portfolio Holdings
Bio Impact Capital LLC
- $669 Million
- Q4 2024
Bio Impact Capital LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $669 Million distributed in 47 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $93.2M, Crinetics Pharmaceuticals, Inc. with a value of $31.5M, Edgewise Therapeutics, Inc. with a value of $28.8M, Insmed Inc with a value of $26.9M, and Natera, Inc. with a value of $25.4M.
Examining the 13F form we can see an increase of $27.7M in the current position value, from $641M to 669M.
Bio Impact Capital LLC is based out at Cambridge, MA
Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.